Get started
Pfizer, Inc.Pfizer, Inc.Pfizer, Inc.

Pfizer, Inc.

No trades
No trades
OverviewFinancialsDocumentsNewsCommunityTechnicalsForecastsSeasonalsOptionsETFsBonds
Full chart
Full chart

Compare with Pfizer, Inc.



Key facts today


Pfizer (PFE) refocuses on its drug pipeline and deals, targeting China and obesity for growth, using AI and cost cuts to boost competitiveness while awaiting key clinical readouts and policy pilots. 1
Analyze the impactAnalyze the impact

Key stats


Market capitalization
‪157.99 B‬ USD
Dividend yield (indicated)
6.20%
Price to earnings Ratio (TTM)
36.71
Basic EPS (TTM)
0.76 USD
Net income (FY)
‪7.77 B‬ USD
Revenue (FY)
‪62.58 B‬ USD
Shares float
‪5.69 B‬
Beta (1Y)
0.45

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Employees


Employees (FY)
‪75 K‬
Change (1Y)
‪−6 K‬−7.41%
Revenue / Employee (1Y)
‪834.39 K‬ USD
Net income / Employee (1Y)
‪103.28 K‬ USD

Company info


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Albert Bourla
Website
pfizer.com
Headquarters
New York
Founded
1849
IPO date
Jan 17, 1944
ISIN
US7170811035
CUSIP
717081103
FIGI
BBG000BR2B91
Identifiers
ISIN US7170811035
CFI code
ESVUFR
Pfizer Inc is a research-based global biopharmaceutical company. It engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Highest yielding bonds


6.587% YTM
Maturity dateJun 15, 2043
Coupon2.74% (Fixed)
6.310% YTM
Maturity dateMay 19, 2063
Coupon5.34% (Fixed)
6.264% YTM
Maturity dateNov 15, 2065
Coupon5.70% (Fixed)
6.211% YTM
Maturity dateMay 19, 2053
Coupon5.30% (Fixed)
6.179% YTM
Maturity dateSep 15, 2048
Coupon4.20% (Fixed)
6.129% YTM
Maturity dateMar 15, 2049
Coupon4.00% (Fixed)
6.103% YTM
Maturity dateDec 15, 2046
Coupon4.13% (Fixed)
6.089% YTM
Maturity dateMay 19, 2043
Coupon5.11% (Fixed)
6.079% YTM
Maturity dateJun 15, 2043
Coupon4.30% (Fixed)
6.059% YTM
Maturity dateNov 15, 2055
Coupon5.60% (Fixed)
6.030% YTM
Maturity dateMay 28, 2050
Coupon2.70% (Fixed)

See all PFE bonds 

ETFs holding the stock


VTI
Vanguard Morningstar Total Stock Market ETF
Weight0.20%
Market value‪4.54 B‬
VOO
Vanguard S&P 500 ETF
Weight0.22%
Market value‪3.74 B‬
IVV
iShares Core S&P 500 ETF
Weight0.24%
Market value‪1.99 B‬
SPY
SPDR S&P 500 ETF TRUST
Weight0.24%
Market value‪1.94 B‬
VTV
Vanguard Morningstar Value ETF
Weight0.53%
Market value‪1.36 B‬
XLV
State Street Health Care Select Sector SPDR ETF
Weight2.65%
Market value‪1.14 B‬
HDV
iShares Core High Dividend ETF
Weight4.67%
Market value‪716.78 M‬
VYM
Vanguard High Dividend Yield ETF
Weight0.58%
Market value‪573.41 M‬
DVY
iShares Select Dividend ETF
Weight2.24%
Market value‪528.44 M‬
FDL
First Trust Morningstar ETF
Weight6.39%
Market value‪510.03 M‬
TDIV
VanEck Vectors ETFs NV - Morningstar Dev. Mrkts. Div. Ldrs.
Weight4.05%
Market value‪452.39 M‬

Explore more ETFs 

Frequently asked questions


The current price of PFE is 27.75 USD — it has increased by 0.12% in the past 24 hours. Watch Pfizer, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Pfizer, Inc. stocks are traded under the ticker PFE.
PFE stock has fallen by −2.89% compared to the previous week, the month change is a 4.10% rise, over the last year Pfizer, Inc. has showed a 11.86% increase.
We've gathered analysts' opinions on Pfizer, Inc. future price: according to them, PFE price has a max estimate of 35.75 USD and a min estimate of 25.00 USD. Watch PFE chart and read a more detailed Pfizer, Inc. stock forecast: see what analysts think of Pfizer, Inc. and suggest that you do with its stocks.
PFE reached its all-time high on Dec 20, 2021 with the price of 61.71 USD, and its all-time low was 0.38 USD and was reached on Mar 14, 1968. View more price dynamics on PFE chart.
See other stocks reaching their highest and lowest prices.
PFE stock is 1.81% volatile and has beta coefficient of 0.45. Track Pfizer, Inc. stock price on the chart and check out the list of the most volatile stocks — is Pfizer, Inc. there?
Today Pfizer, Inc. has the market capitalization of ‪157.99 B‬, it has increased by 3.57% over the last week.
Yes, you can track Pfizer, Inc. financials in yearly and quarterly reports right on TradingView.
Pfizer, Inc. is going to release the next earnings report on Nov 3, 2026. Keep track of upcoming events with our Earnings Calendar.
PFE earnings for the last quarter are 0.77 USD per share, whereas the estimation was 0.68 USD resulting in a 12.88% surprise. The estimated earnings for the next quarter are 0.76 USD per share. See more details about Pfizer, Inc. earnings.
Pfizer, Inc. revenue for the last quarter amounts to ‪15.03 B‬ USD, despite the estimated figure of ‪14.40 B‬ USD. In the next quarter, revenue is expected to reach ‪15.93 B‬ USD.
PFE net income for the last quarter is ‪−248.00 M‬ USD, while the quarter before that showed ‪2.69 B‬ USD of net income which accounts for 0.00% change. Track more Pfizer, Inc. financial stats to get the full picture.
Yes, PFE dividends are paid quarterly. The last dividend per share was 0.43 USD. As of today, Dividend Yield (TTM)% is 6.20%. Tracking Pfizer, Inc. dividends might help you take more informed decisions.
Pfizer, Inc. dividend yield was 6.91% in 2025, and payout ratio reached 126.85%. The year before the numbers were 6.37% and 120.11% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 14, 2026, the company has ‪75 K‬ employees. See our rating of the largest employees — is Pfizer, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Pfizer, Inc. EBITDA is ‪23.51 B‬ USD, and current EBITDA margin is 37.87%. See more stats in Pfizer, Inc. financial statements.
Like other stocks, PFE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Pfizer, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Pfizer, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Pfizer, Inc. stock shows the neutral signal. See more of Pfizer, Inc. technicals for a more comprehensive analysis.